Health management

• Clinical outcomes, health care resource utilization and costs by renal function in patients with heart failure

  Martín Romo, Claudia Yuste, Jorge Vélez, Miguel Hernández, Beatriz Palacios, Raquel Pita, Margarita Capel, Sandra Fernández Fernández, Nicolás Rosillo, Guillermo Moreno, Manuel del Oro, Carmen Ortega, José L. Bernal, Héctor Bueno

  Rev Esp Cardiol. 2026;79:247-56

• The continuity of care in primary care is associated with a more favorable prognosis in patients referred to a cardiology service

  Sergio Cinza-Sanjurjo, Pilar Mazón-Ramos, Daniel Rey-Aldana, Alfonso Varela-Román, Manuel Portela-Romero, José R. González-Juanatey

  Rev Esp Cardiol. 2025;78:1033-40

• Weekend and holiday admissions for decompensated heart failure and in-hospital mortality. A cumulative effect of “nonworking” days?

  Javier Elola, Cristina Fernández-Pérez, Náyade del Prado, José Luis Bernal, Nicolás Rosillo, Marian Bas, Antonio Fernández-Ortiz, Raquel Barba, Juana Carretero-Gómez, Julián Pérez-Villacastín

  Rev Esp Cardiol. 2024;77:440-7

• Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settings

  Cristina Capdevila Aguilera, Emili Vela Vallespín, Montse Clèries Escayola, Sergi Yun Viladomat, Coral Fernández Solana, Laia Alcober Morte, David Monterde Prat, Encarna Hidalgo Quirós, Esther Calero Molina, Núria José Bazán, Pedro Moliner Borja, Jordi Piera Jiménez, Marta Ruiz Muñoz, Xavier Corbella Virós, Santiago Jiménez-Marrero, Alberto Garay Melero, Raúl Ramos Polo, Lidia Alcoberro Torres, Alexandra Pons Riverola, Cristina Enjuanes Grau, Josep Comín-Colet

  Rev Esp Cardiol. 2023;76:803-12

• Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

  Ángel Cequier, Héctor Bueno, Carlos Macaya, Vicente Bertomeu, José R. González-Juanatey, Andrés Íñiguez, Manuel Anguita, Ignacio Cruz, David Calvo, Juan José Gómez-Doblas, José M. de la Torre Hernández, Náyade del Prado, Luis Rodríguez Padial, Julián Pérez-Villacastín, José Luis Bernal, Cristina Fernández Pérez, Javier Elola, por los investigadores del proyecto RECALCAR

  Rev Esp Cardiol. 2023;76:519-30

• Interregional variability in the use of cardiovascular technologies (2011-2019). Correlation with economic indicators, admissions, and in-hospital mortality

  José M. de la Torre Hernández, Manuel Lozano González, Tamara García Camarero, David Serrano Lozano, Belén Cid, Soledad Ojeda, Pilar Jiménez Quevedo, Ana Serrador, Bruno García del Blanco, José F. Díaz, Raúl Moreno, Ignacio Cruz-González, Armando Pérez de Prado, Ignacio Fernández Lozano, Óscar Cano Pérez, David Cantarero Prieto

  Rev Esp Cardiol. 2022;75:805-15

• Universal electronic consultation (e-consultation) program of a cardiology service. Long-term results

  Daniel Rey-Aldana, Sergio Cinza-Sanjurjo, Manuel Portela-Romero, José L. López-Barreiro, Alberto Garcia-Castelo, José M. Pazos-Mareque, Pilar Mazón-Ramos, José R. González-Juanatey

  Rev Esp Cardiol. 2022;75:159-65

• Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain

  Vivencio Barrios, Sergio Cinza-Sanjurjo, Olga Gavín, Isabel Egocheaga, Ramón Burgos-Pol, Javier Soto, Carlos Polanco, Jorge Suárez, Miguel Ángel Casado

  Rev Esp Cardiol. 2021;74:773-80

• Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

  Iñaki Lekuona, Manuel Anguita, José Luis Zamorano, José Manuel Rodríguez, Paloma Barja de Soroa, Ferran Pérez-Alcántara

  Rev Esp Cardiol. 2019;72:398-406

• Start-up of a Cardiology Day Hospital: Activity, Quality Care and Cost-effectiveness Analysis of the First Year of Operation

  María Gallego-Delgado, Eduardo Villacorta, M. Carmen Valenzuela-Vicente, Ángela Walias-Sánchez, Carmen Ávila, M. Jesús Velasco-Cañedo, M. Teresa Cano-Mozo, Agustín Martín-García, María Jesús García-Sánchez, Argelina Sánchez, Manuel Cascón, Pedro L. Sánchez

  Rev Esp Cardiol. 2019;72:130-7

• Cost-effectiveness and Budget Impact of Treatment with Evolocumab Versus Statins and Ezetimibe for Hypercholesterolemia in Spain

  Antonio Olry de Labry Lima, Vicente Gimeno Ballester, Jesús Francisco Sierra Sánchez, Antonio Matas Hoces, Julio González-Outón, Emilio Jesús Alegre del Rey

  Rev Esp Cardiol. 2018;71:1027-35

• Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol

  Ji-won Hwang, Eun Kyoung Kim, Shin Yi Jang, Tae-Young Chung, Chang-Seok Ki, Kiick Sung, Sung Mok Kim, Joonghyun Ahn, Keumhee Carriere, Yeon Hyeon Choe, Sung-A. Chang, Duk-Kyung Kim

  Rev Esp Cardiol. 2018;71:743-9

• Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study

  Vivencio Barrios, Lisette Kaskens, José María Castellano, Juan Cosin-Sales, José Emilio Ruiz, Ilonka Zsolt, Valentín Fuster, Alfredo Gracia

  Rev Esp Cardiol. 2017;70:42-9

• Effectiveness and Factors Determining the Success of Management Programs for Patients With Heart Failure: A Systematic Review and Meta-analysis

  Juana Oyanguren, Pedro María Latorre García, Jesús Torcal Laguna, Iñaki Lekuona Goya, Susana Rubio Martín, Elena Maull Lafuente, Gonzalo Grandes

  Rev Esp Cardiol. 2016;69:900-14

• InnovaSEC in Action: Cost-effectiveness of Barostim in the Treatment of Refractory Hypertension in Spain

  Marcelo Soto, Laura Sampietro-Colom, Joan Sagarra, Josep Brugada-Terradellas

  Rev Esp Cardiol. 2016;69:563-71

• A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems

  Antonio López-Villegas, Daniel Catalán-Matamoros, Carlos Martín-Saborido, Irene Villegas-Tripiana, Emilio Robles-Musso

  Rev Esp Cardiol. 2016;69:125-33

• A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain

  Josep Comín-Colet, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, Cristina Enjuanes-Grau, Florian S. Gutzwiller, Stefan D. Anker, Piotr Ponikowski

  Rev Esp Cardiol. 2015;68:846-51

• Economic Impact of Heart Failure According to the Effects of Kidney Failure

  Antoni Sicras Mainar, Ruth Navarro Artieda, Jordi Ibáñez Nolla

  Rev Esp Cardiol. 2015;68:39-46

• Health Care and Nonhealth Care Costs in the Treatment of Patients With Symptomatic Chronic Heart Failure in Spain

  Juan F. Delgado, Juan Oliva, Miguel Llano, Domingo Pascual-Figal, José J. Grillo, Josep Comín-Colet, Beatriz Díaz, León Martínez de La Concha, Belén Martí, Luz M. Peña

  Rev Esp Cardiol. 2014;67:643-50

• Efficacy of an Integrated Hospital-primary Care Program for Heart Failure: A Population-based Analysis of 56 742 Patients

  Josep Comín-Colet, José María Verdú-Rotellar, Emili Vela, Montse Clèries, Montserrat Bustins, Lola Mendoza, Neus Badosa, Mercè Cladellas, Sofía Ferré, Jordi Bruguera, on behalf of the working group of the Integrated Program for Heart Failure Management of the Barcelona Litoral Mar Integrated Health Care Area, Spain

  Rev Esp Cardiol. 2014;67:283-93